BRIEF-Johnson & Johnson to undertake an investigational study for HIV Vaccine

Johnson & Johnson: * J&J - PHASE 3 EFFICACY STUDY FOR INVESTIGATIONAL JANSSEN PREVENTIVE HIV VACCINE PLANNED TO TAKE PLACE

* J&J - CO'S STUDY FOR INVESTIGATIONAL HIV VACCINE PLANNED TO TAKE PLACE IN MULTIPLE COUNTRIES ACROSS NORTH AMERICA, SOUTH AMERICA, EUROPE * J&J, ON STUDY FOR INVESTIGATIONAL HIV VACCINE, SAYS IN PROCESS OF SUBMITTING REGULATORY APPLICATIONS TO RESPECTIVE HEALTH AUTHORITIES Further company coverage: